Blue Jet Healthcare Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Sep 2025 is -53.35% vs 4.20% in Jun 2025

Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is -42.81% vs -17.19% in Jun 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is -54.59% vs -13.56% in Jun 2025

Interest

QoQ Growth in quarter ended Sep 2025 is 571.01% vs 2,200.00% in Jun 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

Compare Quarterly Results Of Blue Jet Health With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

165.48

475.40

-309.92

-65.19%

Other Operating Income

0.00

Total Operating income

165.48

475.40

-309.92

-65.19%

Raw Material Cost

108.42

53.30

55.12

103.41%

Purchase of Finished goods

0.00

269.80

-269.80

-100.00%

(Increase) / Decrease In Stocks

-50.56

-83.20

32.64

39.23%

Employee Cost

18.55

41.90

-23.35

-55.73%

Power Cost

0.00

Manufacturing Expenses

0.01

0.00

0.01

Selling and Distribution Expenses

0.00

Other Expenses

34.11

59.40

-25.29

-42.58%

Total Expenditure (Excl Depreciation)

110.53

341.20

-230.67

-67.61%

Operating Profit (PBDIT) excl Other Income

54.95

134.20

-79.25

-59.05%

Other Income

24.27

4.90

19.37

395.31%

Operating Profit (PBDIT)

79.22

139.10

-59.88

-43.05%

Interest

4.63

0.40

4.23

1,057.50%

Exceptional Items

0.00

-27.30

27.30

100.00%

Gross Profit (PBDT)

74.59

111.40

-36.81

-33.04%

Depreciation

5.87

9.10

-3.23

-35.49%

Profit Before Tax

68.73

102.30

-33.57

-32.82%

Tax

16.59

26.30

-9.71

-36.92%

Provisions and contingencies

0.00

Profit After Tax

52.14

76.00

-23.86

-31.39%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

52.14

76.00

-23.86

-31.39%

Equity Capital

34.69

23.00

11.69

50.83%

Face Value

2.00

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

3.01

33.04

-30.03

-90.89%

Diluted Earnings per share

3.01

32.99

-29.98

-90.88%

Operating Profit Margin (Excl OI)

33.21%

28.23%

0.00

4.98%

Gross Profit Margin

45.07%

23.43%

0.00

21.64%

PAT Margin

31.51%

15.99%

0.00

15.52%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 165.48 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is -53.35% vs 4.20% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -20.54% vs 14.84% in Sep 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 52.14 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is -42.81% vs -17.19% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -10.64% vs 21.89% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 54.95 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is -54.59% vs -13.56% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -20.92% vs 10.97% in Sep 2024

Quarterly - Interest

Interest 4.63 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 571.01% vs 2,200.00% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 23,050.00% vs -50.00% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 33.21%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024